GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a significant focus in therapeutic research, largely due to its notable impact on controlling diseases such as second type diabetes and weight gain. Ongoing research have revealed that more than glucose regulation, GLP-1 medications offer promise for cardiovascular health a